Adding 6 months of maintenance chemotherapy appears to improve survival for patients with high-risk rhabdomyosarcoma (RMS) and will be the new standard of care in future European clinical trials, ...
The rhabdomyosarcoma market is expanding as unmet needs in pediatric and young-adult populations drive increased R&D and clinical activity. Additionally, the launch of emerging therapies such as ...
CONCLUSION: This analysis demonstrates that the probability of 5-year survival after relapse for rhabdomyosarcoma is dependent on several factors at the time of initial diagnosis, including histologic ...
Rhabdomyosarcoma (RMS) accounts for up to 10% of childhood cancers and nearly half of pediatric soft tissue sarcomas. While multimodal therapies have improved outcomes for low- and intermediate-risk ...
Scientists at St. Jude Children's Research Hospital have revealed how the tumor suppressor gene PTEN plays a more important role in pediatric rhabdomyosarcoma than was previously appreciated. The ...
Embryonal rhabdomyosarcoma of the uterine cervix is an uncommon presentation of the most common soft-tissue sarcoma in the first decades of life. Unlike embryonal rhabdomyosarcoma in other anatomic ...
Rhabdomyosarcoma is a type of soft tissue cancer. Scientists at St. Jude Children's Research Hospital studied the population of cells that persists after therapy, causing rhabdomyosarcoma recurrence.
Biology and Management of Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Malignant Peripheral Nerve Sheath Tumors: State of the Art and Perspectives Several recent advances have been made ...
Are you searching for effective medications to treat 'Rhabdomyosarcoma'? This comprehensive guide provides the latest information on medications-both generic and branded-that are essential for ...
PRIMARY rhabdomyosarcoma of the tongue is a rare condition to which no reference is available for a complete pathological description or a sound therapeutic approach. The physician confronted with a ...
Small spots on CT scans of the lungs of children with muscle cancer do not have an adverse effect on survival according to an international research team. This conclusion has direct consequences for ...
Background A 29-year-old male patient presented with a history of painless enlargement of the left hemiscrotum. Investigations Laboratory tests for β-human chorionic gonadotrophin, α-fetoprotein, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results